SillaJen, Inc.

₩1,960As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:215600Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (16.98%)
Div yield —
ROE (21.50%)
Biotechnology
Beta (5Y) 0.13
PE TTM —
TSR TTM (31.71%)
Mkt cap ₩271.6B
ROIC (14.31%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,929
(1.57%)
231.60%
Buy 4|10|8|2|0
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
23.77
24.12
23.19
25.18
14.26%
8.52%
8.71%
6.87%
Revenue₩B
29.58
29.19
30.85
32.42
0.52%
(4.32%)
4.21%
12.52%
Peers (US$200.2M)
Cap (US$)
PE
244.4M
—
239.9M
—
Capital
TTM
5Y
10Y
Leveragex
0.718
—
—
EBIT/Intx
0.277
1.301
0.893
Own earn%
19.93
(101.64)
(100.04)
Sh yield%
38.15
30.02
33.18
Owners
Insiders/Inst%
4.33
86.06
Short interest%
0.91
SBC / revenue%
5.01
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
6–12
$1 testx
0.2
Incr. ROIC%
5